Cargando…

GAS2L1 Is a Potential Biomarker of Circulating Tumor Cells in Pancreatic Cancer

SIMPLE SUMMARY: The analysis of circulating tumor cells (CTC) is a mainstay of liquid biopsy of solid malignancies. However, research to date has not yet determined a universal and specific marker for CTCs of pancreatic cancer. Genetically engineered mouse models (GEMMs) of pancreatic cancer, can mi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Lei, Kan, Ke-Jia, Grün, Johanna L., Hissa, Barbara, Yang, Cui, Győrffy, Balázs, Loges, Sonja, Reißfelder, Christoph, Schölch, Sebastian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7765300/ https://www.ncbi.nlm.nih.gov/pubmed/33333841 http://dx.doi.org/10.3390/cancers12123774

Ejemplares similares

Characterization of Stem-like Circulating Tumor Cells in Pancreatic Cancer
por: Zhu, Lei, et al.
Publicado: (2020)

Circulating tumour cells in patients with lung cancer universally indicate poor prognosis
por: Jin, Fukang, et al.
Publicado: (2022)

Postoperative course and prognostic value of circulating angiogenic cytokines after pancreatic cancer resection
por: Yang, Cui, et al.
Publicado: (2017)

Serum PlGF and EGF are independent prognostic markers in non-metastatic colorectal cancer
por: Schölch, Sebastian, et al.
Publicado: (2019)

Prognostic value of circulating endothelial cells in metastatic colorectal cancer
por: Rahbari, Nuh N, et al.
Publicado: (2017)

LDB1 overexpression is a negative prognostic factor in colorectal cancer
por: García, Sebastián A., et al.
Publicado: (2016)

Weekday-dependent long-term outcomes in gastrointestinal cancer surgery: a German population-based retrospective cohort study
por: Maier, Christopher F., et al.
Publicado: (2023)

Circulating tumour cells and outcome in non-metastatic colorectal cancer: a prospective study
por: Bork, U, et al.
Publicado: (2015)

Robot-assisted esophagectomy may improve perioperative outcome in patients with esophageal cancer – a single-center experience
por: Betzler, Johanna, et al.
Publicado: (2022)

Circulating tumor cells exhibit stem cell characteristics in an orthotopic mouse model of colorectal cancer
por: Schölch, Sebastian, et al.
Publicado: (2016)

Differential Effects of Trp53 Alterations in Murine Colorectal Cancer
por: Betzler, Alexander M., et al.
Publicado: (2021)

Inhibition of Six1 affects tumour invasion and the expression of cancer stem cell markers in pancreatic cancer
por: Lerbs, Tristan, et al.
Publicado: (2017)

Detection of Circulating Tumor Cells in Non-Small Cell Lung Cancer
por: Hanssen, Annkathrin, et al.
Publicado: (2015)

The Influence of Pretherapeutic and Preoperative Sarcopenia on Short-Term Outcome after Esophagectomy
por: Grün, Johanna, et al.
Publicado: (2020)

Discovery and ranking of the most robust prognostic biomarkers in serous ovarian cancer
por: Győrffy, Balázs
Publicado: (2023)

Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancer
por: Győrffy, Balázs
Publicado: (2021)

New Transcriptomic Biomarkers of 5-Fluorouracil Resistance
por: Fekete, János Tibor, et al.
Publicado: (2023)

Analysis of a large cohort of pancreatic cancer transcriptomic profiles to reveal the strongest prognostic factors
por: Posta, Máté, et al.
Publicado: (2023)

Long-peptide vaccination with driver gene mutations in p53 and Kras induces cancer mutation-specific effector as well as regulatory T cell responses
por: Quandt, Jasmin, et al.
Publicado: (2018)

Molecular stratifications, biomarker candidates and new therapeutic options in current medulloblastoma treatment approaches
por: Menyhárt, Otília, et al.
Publicado: (2020)

Molecular pathology of thymomas: implications for diagnosis and therapy
por: Marx, Alexander, et al.
Publicado: (2021)

Determining consistent prognostic biomarkers of overall survival and vascular invasion in hepatocellular carcinoma
por: Menyhárt, Otília, et al.
Publicado: (2018)

A Comprehensive MicroRNA Expression Profile of Liver and Lung Metastases of Colorectal Cancer with Their Corresponding Host Tissue and Its Prognostic Impact on Survival
por: Pecqueux, Mathieu, et al.
Publicado: (2016)

Circulating nucleosomes as epigenetic biomarkers in pancreatic cancer
por: Bauden, Monika, et al.
Publicado: (2015)

A unified platform enabling biomarker ranking and validation for 1562 drugs using transcriptomic data of 1250 cancer cell lines
por: Tibor Fekete, János, et al.
Publicado: (2022)

Gene expression-based biomarkers designating glioblastomas resistant to multiple treatment strategies
por: Menyhárt, Otília, et al.
Publicado: (2021)

Predictive biomarkers of immunotherapy response with pharmacological applications in solid tumors
por: Kovács, Szonja Anna, et al.
Publicado: (2023)

Circulating microRNAs in Pancreatic Juice as Candidate Biomarkers of Pancreatic Cancer
por: Wang, Jin, et al.
Publicado: (2014)

Editorial: Novel circulating biomarkers and radiomics in pancreatic cancer
por: Ren, Shuai, et al.
Publicado: (2023)

Patient-Derived Organoids of Cholangiocarcinoma
por: Maier, Christopher Fabian, et al.
Publicado: (2021)

Mutations Defining Patient Cohorts With Elevated PD-L1 Expression in Gastric Cancer
por: Menyhárt, Otília, et al.
Publicado: (2019)

Vasostatin-1: A novel circulating biomarker for ileal and pancreatic neuroendocrine neoplasms
por: Corsello, Andrea, et al.
Publicado: (2018)

Circulating Nucleic Acids as Novel Biomarkers for Pancreatic Ductal Adenocarcinoma
por: McGowan, Ryan, et al.
Publicado: (2022)

Role of circulating exosomal biomarkers and their diagnostic accuracy in pancreatic cancer
por: Sha, Menazir, et al.
Publicado: (2022)

Online Survival Analysis Software to Assess the Prognostic Value of Biomarkers Using Transcriptomic Data in Non-Small-Cell Lung Cancer
por: Győrffy, Balázs, et al.
Publicado: (2013)

c-Met and PD-L1 on Circulating Exosomes as Diagnostic and Prognostic Markers for Pancreatic Cancer
por: Lux, Alexander, et al.
Publicado: (2019)

Determination of PD-L1 Expression in Circulating Tumor Cells of NSCLC Patients and Correlation with Response to PD-1/PD-L1 Inhibitors
por: Janning, Melanie, et al.
Publicado: (2019)

Identification of circulating extracellular vesicle long RNAs as diagnostic biomarkers for patients with severe acute pancreatitis
por: Zhu, Qingfu, et al.
Publicado: (2022)

Clinical impact of duodenal pancreatic heterotopia – Is there a need for surgical treatment?
por: Betzler, Alexander, et al.
Publicado: (2017)

Comparison of Tumour-Specific Phenotypes in Human Primary and Expandable Pancreatic Cancer Cell Lines
por: Guo, Feng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_igaflsrhvn6k4163eslrjt3110